Stay updated with breaking news from B Pfizer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer and BioNTech are reportedly preparing to ask the Food and Drug Administration to authorize a COVID-19 vaccine for kids younger than 5.
U.S. regulators are planning to review and authorize Pfizer and BioNTech's COVID-19 vaccine for children younger than 5 before data on a third -- and potentially necessary -- shot is available.
Pfizer and BioNTech on Tuesday launched a clinical study to evaluate the safety and efficacy of a COVID-19 vaccine that targets omicron, the globally dominant variant.
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant.
Pfizer and BioNTech on Tuesday launched a clinical study to evaluate the safety and efficacy of a COVID-19 vaccine that targets omicron, the globally dominant variant.